What's new

Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 25, Status: Authorised

Jun 18, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Scholar Rock says its drug preserved lean mass in patients taking Zepound

Next Article

Turkish Aerospace eyes full development of local Kaan fighter jet engine by 2032

Related Posts

Summary of opinion: Nexgard Spectra, 12/06/2025 Positive

Summary of opinion: Nexgard Spectra, 12/06/2025 Positive

Jun 13, 2025  0

Article 57 product data

May 14, 2025  0

Orphan designation: small-interfering RNA against soluble fms-like tyrosine kinase-1 e15a mRNA, small-interfering RNA against soluble fms-like tyrosine kinase-1 i13 mRNA Treatment of pre-eclampsia, 16/04/2025 Positive

Orphan designation: small-interfering RNA against solub...

Jun 5, 2025  0